ELOX · Company research
Eloxx Pharmaceuticals, Inc. Common Stock (ELOX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| ELOX stock enters a 24 patient Phase 2b kidney trial - AD HOC NEWS | ELOX stock enters a 24 patient Phase 2b kidney trial AD HOC NEWS | View source ↗ | AD HOC NEWS | Sep 30, 2026 | neutral | 0 | 0.6 |
| Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Short Interest Update - MarketBeat | Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Short Interest Update MarketBeat | View source ↗ | MarketBeat | Sep 30, 2026 | neutral | 0 | 0.6 |
| Eloxx Pharmaceuticals, Inc. SEC Filing (Sep 21, 2026) - Stock Titan | Eloxx Pharmaceuticals, Inc. SEC Filing (Sep 21, 2026) Stock Titan | View source ↗ | Stock Titan | Sep 21, 2026 | neutral | 0 | 0.6 |
| ELOX: Eloxx Pharmaceuticals Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits | ELOX: Eloxx Pharmaceuticals Inc Latest Stock Price, Analysis, News and Trading Ideas Stocktwits | View source ↗ | Stocktwits | Sep 11, 2026 | neutral | 0 | 0.6 |
| Two patients start a trial for a genetic kidney disease with no FDA-approved therapy for its cause - Stock Titan | Two patients start a trial for a genetic kidney disease with no FDA-approved therapy for its cause Stock Titan | View source ↗ | Stock Titan | Sep 11, 2026 | neutral | 0 | 0.6 |
| Analysts Offer Insights on Healthcare Companies: Eloxx Pharmaceuticals (ELOX), Cingulate Inc (CING) and Agilon Health (AGL) - The Globe and Mail | Analysts Offer Insights on Healthcare Companies: Eloxx Pharmaceuticals (ELOX), Cingulate Inc (CING) and Agilon Health (AGL) The Globe and Mail | View source ↗ | The Globe and Mail | Aug 25, 2026 | neutral | 0 | 0.6 |
| Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) Share Price, ELOX Stock News, ELOX Share Price & Updates - kalkine.ca | Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) Share Price, ELOX Stock News, ELOX Share Price & Updates kalkine.ca | View source ↗ | kalkine.ca | Aug 18, 2026 | neutral | 0 | 0.6 |
| Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update - PR Newswire | Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update PR Newswire | View source ↗ | PR Newswire | Aug 12, 2026 | neutral | 0 | 0.6 |
| ELOX Forecast — Price Target — Prediction for 2027 - TradingView | ELOX Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jul 26, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Jun 10, 2026 | neutral | 0 | 0.6 |
| Eloxx Pharma Raises $66M for Nasdaq Uplisting - AllSci | Eloxx Pharma Raises $66M for Nasdaq Uplisting AllSci | View source ↗ | AllSci | Jun 10, 2026 | neutral | 0 | 0.6 |
| Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq - PR Newswire | Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq PR Newswire | View source ↗ | PR Newswire | Jun 8, 2026 | neutral | 0 | 0.6 |
| Eloxx Pharmaceuticals Stock Price Forecast. Should You Buy ELOX? - StockInvest.us | Eloxx Pharmaceuticals Stock Price Forecast. Should You Buy ELOX? StockInvest.us | View source ↗ | StockInvest.us | Dec 16, 2020 | neutral | 0 | 0.6 |
| Eloxx Pharmaceuticals, Inc. (ELOX) Stock Price, News, Quote & History - Yahoo! Finance Canada | Eloxx Pharmaceuticals, Inc. (ELOX) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Jun 17, 2018 | neutral | 0 | 0.6 |
| Eloxx Pharmaceuticals (Nasdaq:ELOX) - Stock Analysis - Simply Wall Street | Eloxx Pharmaceuticals (Nasdaq:ELOX) - Stock Analysis Simply Wall Street | View source ↗ | Simply Wall Street | Apr 28, 2018 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.